MEDIHALER ERGOTAMINE Drug Patent Profile
When do Medihaler Ergotamine patents expire, and what generic alternatives are available?
Medihaler Ergotamine is a drug marketed by 3M and is included in one NDA.
The generic ingredient in MEDIHALER ERGOTAMINE is ergotamine tartrate. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the ergotamine tartrate profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for MEDIHALER ERGOTAMINE?
- What are the global sales for MEDIHALER ERGOTAMINE?
- What is Average Wholesale Price for MEDIHALER ERGOTAMINE?
Summary for MEDIHALER ERGOTAMINE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 24 |
| Patent Applications: | 53 |
| DailyMed Link: | MEDIHALER ERGOTAMINE at DailyMed |
US Patents and Regulatory Information for MEDIHALER ERGOTAMINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3m | MEDIHALER ERGOTAMINE | ergotamine tartrate | AEROSOL, METERED;INHALATION | 012102-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
